Biomarkers – News and Features

Biomarkers used to diagnose Alzheimer's vary significantly depending on the time of day, with levels being low in the morning and higher in the evening.

In this article, explore how next-generation protein sequencing is helping to unlock the proteome.

Regulatory B cells can be analyzed to monitor the risk of damage and rejection in kidney transplant patients, a new study finds.

A study reduced the complexity of fMRI data to identify stable brain activity patterns shared among over 300 individuals. This may aid in uncovering biomarkers for psychiatric disorders.

Some bacterial species that live in people’s mouths have been linked to a collective 50% increased chance of developing a type of head and neck cancer, a new study shows.

Research conducted as part of the COVID-CNS Consortium shows that 12-18 months after hospitalization due to COVID-19, patients have worse cognitive function than matched control participants.

A study at UT Dallas reveals that X-ray imaging using gold nanoparticles offers superior accuracy in detecting kidney disease compared to traditional blood tests like BUN and creatinine.

Technology Networks interviewed Professor Henrik Zetterberg on World Alzheimer’s Day 2024 to learn more about his work and his outlook on the future of AD and dementia research.

Researchers developed innovative origami-paper sensors for detecting infectious disease biomarkers in wastewater. This low-cost, user-friendly method allows for rapid results via mobile phone cameras.

Researchers found that blackcurrant supplements helped prevent bone density loss in peri- and post-menopausal women. In a six-month trial, those taking two capsules daily showed increased bone density.